Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNC012490

Drug Information
NameN-Indan-1-yl-2-(1H-indol-3-yl)-2-oxo-acetamide
IndicationNot AvailableExperimental    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C19H16N2O2/c22-18(15-11-20-16-8-4-3-7-14(15)16)19(23)21-17-10-
9-12-5-1-2-6-13(12)17/h1-8,11,17,20H,9-10H2,(H,21,23)
InChIKeyHPOOEGNMALNZJV-UHFFFAOYSA-N
Canonical SMILESC1CC2=CC=CC=C2C1NC(=O)C(=O)C3=CNC4=CC=CC=C43    
TargetGABA receptor alpha-1 subunitInhibitor[1]
GABA receptor beta-2 subunitInhibitor[1]
GABA receptor beta-3 subunitInhibitor[1]
GABA receptor gamma-2 subunitInhibitor[1]
Ref 1J Med Chem. 2001 Jul 5;44(14):2286-97.Novel N-(arylalkyl)indol-3-ylglyoxylylamides targeted as ligands of the benzodiazepine receptor: synthesis, biological evaluation, and molecular modeling analysis of the structure-activity relationships. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543